CAS 864070-44-0
:Empagliflozin
Description:
Empagliflozin is a medication primarily used in the management of type 2 diabetes mellitus. It belongs to the class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, which function by preventing the reabsorption of glucose in the kidneys, thereby promoting its excretion in urine and lowering blood glucose levels. The chemical formula of empagliflozin reflects its complex structure, which includes a glucose moiety linked to a substituted aromatic ring. This compound exhibits a high degree of selectivity for the SGLT2 transporter, making it effective in reducing hyperglycemia. Additionally, empagliflozin has been associated with cardiovascular benefits and weight loss in patients with diabetes. Its pharmacokinetics indicate good oral bioavailability, with a relatively long half-life, allowing for once-daily dosing. Common side effects may include urinary tract infections and genital mycotic infections due to increased glucose in the urine. Overall, empagliflozin represents a significant advancement in diabetes treatment, contributing to improved glycemic control and cardiovascular outcomes.
Formula:C23H27ClO7
InChI:InChI=1S/C23H27ClO7/c24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/h1-6,10,17,19-23,25-28H,7-9,11-12H2/t17-,19+,20+,21-,22+,23-/m0/s1
InChI key:InChIKey=OBWASQILIWPZMG-QZMOQZSNSA-N
SMILES:O[C@H]1[C@H](C2=CC(CC3=CC=C(O[C@H]4CCOC4)C=C3)=C(Cl)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O
Synonyms:- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-<span class="text-smallcaps">D</span>-glucitol
- <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, (1S)-
- Bi 10773
- D-Glucitol, 1,5-Anhydro-1-C-[4-Chloro-3-[[4-[[(3S)-Tetrahydro-3-Furanyl]Oxy]Phenyl]Methyl]Phenyl]-, (1S)-
- Jardiance
- Empagliflozin
- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol
- D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]M ethyl]phenyl]-, (1S)-
- (1S)-1,5-Anhydro-1-C-{4-chloro-3-[(4-{[(3S)-oxolan-3-yl]oxy}phenyl)methyl]phenyl}-D-glucitol
- Boehringer Ingelheim(BI-44847)
- EMPAGLIFLBZIN
- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol Empagliflozin BI 10773
- (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxyMethyl)-tetrahydro-2H-pyran-3,4,5-triol
- (1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol
- EMpagliflozin/ BI-10773
- See more synonyms
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 18 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Empagliflozin
CAS:EmpagliflozinFormula:C23H27ClO7Purity:98%Color and Shape:SolidMolecular weight:450.909Empagliflozin
CAS:EmpagliflozinFormula:C23H27ClO7Purity:≥98%Color and Shape:SolidMolecular weight:450.91(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol
CAS:Formula:C23H27ClO7Purity:98%Color and Shape:SolidMolecular weight:450.9093Empagliflozin
CAS:Stability Hygroscopic
Applications Empagliflozin is a novel, potent and selective SGLT-2 inhibitor. It improves glycaemic control syndrome in diabetic rats.
References Thomas, L., et al.: Diabetes. Obesity. Metabol. 14, 94 (2012); Grempler, R., et al.: Diabetes. Obesity. Metabol., 14, 83 (2012);Formula:C23H27ClO7Color and Shape:NeatMolecular weight:450.91Empagliflozin
CAS:(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triolFormula:C23H27ClO7Purity:98%Molecular weight:450.91Empagliflozin
CAS:Empagliflozin (BI 10773) is an SGLT-2 inhibitor (IC50=3.1 nM) that is potent and selective, with more than 300-fold selectivity for SGLT-1/4/5/6.Formula:C23H27ClO7Purity:98% - 99.98%Color and Shape:SolidMolecular weight:450.91Empagliflozin
CAS:Potent, selective and competitive inhibitor of sodium-glucose cotransporter SGLT2, which is implicated in renal glucose reabsorption. The compound increases urinary glucose excretion, helps decrease hyperglyceamia and maintains glucose homeostasis in diabetic individuals. It has been associated with weight loss, lower blood pressure and decreased glycated haemoglobin. Animal studies suggest that empagliflozin preserves regeneration of β-cells in pancreatic Langerhans islets.Formula:C23H27ClO7Purity:Min. 98 Area-%Color and Shape:White PowderMolecular weight:450.91 g/molEmpagliflozin (Standard)
CAS:Empagliflozin (Standard) is a reference standard for research and analysis in studies involving Empagliflozin. Empagliflozin (BI 10773) is an SGLT-2 inhibitor (IC50=3.1 nM) that is potent and selective, with more than 300-fold selectivity for SGLT-1/4/5/6. Empagliflozin is used for the treatment of type 2 diabetes.Formula:C23H27ClO7Molecular weight:450.91
![(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-gluci…](https://static.cymitquimica.com/products/IN/thumb/DA0039QH.jpg)
